Jennifer King
Jennifer King
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of Cabozantinib With Patients With Refractory GCTs | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, germinoma, neoplasm, nongerminomatous germ cell tumor, ovarian germ cell tumor, seminoma | Active, not recruiting | Phase 2 | 2026-01-15 | NCT04876456 |